SR One Capital Management
$1.0B 13F equity value
17 Holdings
Latest filing 2026-06-30
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MANE | Veradermics, Inc. | 2,401,868 | $295M | 28.4% |
| ZBIO | Zenas BioPharma, Inc | 5,037,854 | $128M | 12.3% |
| CRSP | CRISPR Therapeutics AG | 2,038,763 | $111M | 10.7% |
| AVLN | Avalyn Pharma, Inc | 3,308,649 | $109M | 10.5% |
| DSGN | Design Therapeutics, Inc. | 6,526,476 | $94M | 9.1% |
| ODTX | Odyssey Therapeutics, Inc. | 3,794,883 | $71M | 6.8% |
| ALMS | Alumis Inc. | 1,959,896 | $55M | 5.3% |
| ORIC | ORIC Pharmaceuticals, Inc. | 4,615,384 | $50M | 4.8% |
| MLYS | Mineralys Therapeutics Inc. | 1,563,966 | $42M | 4.1% |
| SPRY | ARS Pharmaceuticals, Inc. | 4,012,903 | $32M | 3.1% |
Track SR One Capital Management's 13F portfolio: $1.0B in reported holdings, 17 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}